Drug profile · INN
estradiol + norethisterone acetate
ESTALIS CONTINUOUS 50/140
estradiol + norethisterone acetate (ESTALIS CONTINUOUS 50/140) is an FDA-listed pharmaceutical active ingredient. Associated with Sandoz Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 4
News articles 0
Drug details — estradiol + norethisterone acetate
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 4
- Data quality
- 0.81
Quick answer
estradiol + norethisterone acetate (ESTALIS CONTINUOUS 50/140) is an FDA-listed pharmaceutical active ingredient. Associated with Sandoz Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is estradiol + norethisterone acetate?
estradiol + norethisterone acetate (ESTALIS CONTINUOUS 50/140) is an FDA-listed pharmaceutical active ingredient. Associated with Sandoz Pty Ltd.
What is the brand name for estradiol + norethisterone acetate?
ESTALIS CONTINUOUS 50/140 is a marketed brand name for estradiol + norethisterone acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.